Andrew Radonjic – Managing Director – Venture Minerals (ASX:VMS) is dedicated to discovering and developing world-class mineral deposits to meet global demand for critical minerals vital to the green energy transition.
Copyright 2023 – Finance News Network
27 May 2021 - QEM Limited (ASX:QEM) Managing Director Gavin Loyden discusses the invention and advantages of vanadium redox flow batteries with Professor Maria Skyllas-Kazacos of the University of New South Wales.
29 07 2024 - David Flanagan - Managing Director - Arrow Minerals (ASX:AMD) is actively exploring the Simandou North Iron Project (SNIP) in Guinea, West Africa with the intention of discovering and developing a direct shipping grade iron mining operation as soon as possible. The Company intends to take full advantage of the multi-user rail infrastructure currently being developed for the benefit of the Winning Consortium and the SimFer JV due for commissioning from late 2025.
26 Aug 2021 - Chimeric Therapeutics Limited (ASX:CHM) Chief Operating Officer Jennifer Chow talks about the company's licensing of a novel, third-generation CDH17 CAR T cell therapy from the University of Pennsylvania, its recent FDA IND clearance and plans for ongoing growth.
20 Feb 2023 - Etherstack Limited (ASX:ESK) CEO and Executive Director David Deacon discusses the company's 2022 financial highlights and outlook for 2023.
25 Oct 2024 - In the keynote address for the inaugural Semiconductor Australia conference, Digital Playground Co-Founder and General Partner Peter Barrett discusses Australia's potential to lead in next-generation technology.
07 Dec 2020 - ResApp Health Limited (ASX:RAP) CEO and Managing Director Dr Tony Keating provides an update on the company's growing suite of apps for the diagnosis and management of respiratory conditions and sleep apnoea, discussing its launch of the ResAppDx smartphone-based acute respiratory diagnostic test.
08 Jul 2021 - ImpediMed Limited (ASX:IPD) CEO and Managing Director Richard Carreon discusses the company's bioimpedance spectroscopy platform SOZO, which is particularly targeted at noninvasive clinical assessment and monitoring of fluid status and tissue composition in the treatment of secondary lymphoedema, heart failure and renal failure.